Life Technologies | GJELD



Debt Endring Dato
Ardelyx USD 150.85M 50.15M 2024-12
Biogen USD 6.3B 1.9M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Cipla INR 4.61B 980.3M 2024-09
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.91M 2.91M 2024-12
CSL USD 12.18B 76M 2024-06
Galapagos EUR 11.72M 257K 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Grifols EUR 9.23B 626.05M 2024-12
Life Technologies USD 1.43M 128K 2024-12
Novartis USD 31.26B 828M 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
United Therapeutics USD 300M 100M 2024-12



Life Technologies GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.